Great to see more encouraging data from Serac Healthcare on the potential of maraciclatide as a non-invasive diagnostic option for endometriosis being presented at the European Endometriosis Congress taking place today.
Continuing positive results from the DETECT study comparing the imaging of superficial peritoneal endometriosis by ⁹⁹ᵐTc-maraciclatide with laparoscopic surgery are being presented today in a poster by one of the investigators, Dr Tatjana Gibbons from the Nuffield Dept of Women's & Reproductive Health, University of Oxford. The poster will be on display at the 7th European Endometriosis Congress taking place in Bucharest from 6-8 June. For full details, please see the press release here https://lnkd.in/eC42HGhV #endometriosis #womenshealth #molecularimaging #diagnosticimaging #medicalimaging #precisionmedicine #nuclearmedicine #EEC2024 European Endometriosis League Spectrum Dynamics Medical Hermes Medical Solutions Krina Zondervan Maraciclatide is for investigational use only and is not approved by the FDA or UK and European regulatory authorities.